Harvest Hang Seng Healthcare ETF(QDII)(159557.SZ)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
Harvest Hang Seng Healthcare ETF(QDII)
159557.SZ
News
View More

Hong Kong stock market closing | The Hang Seng Index rose by 0.56%, the internet sector strengthened, and Alibaba surged by 5.69%

The three major indices of the Hong Kong stock market all closed higher today, with the Hang Seng Index rising by 0.56%, the Hang Seng TECH Index up by 0.66%, and the National Enterprises Index rebounding moderately. The internet content and information sector performed prominently, with Kuaishou and Alibaba leading the gains, as funds flowed into high-growth industries such as technology and pharmaceuticals. Individual stocks like Alibaba Health and Lion Group Holdings performed outstandingly, while the market's short-term fluctuations focus on macroeconomic and liquidity changes. Investors are advised to continuously monitor policy and profit trends

Market Heartbeat·
Market Heartbeat·

Hong Kong Stock Market Mid-Review | Hang Seng Index rises 0.92%, Internet sector up, Alibaba rises 5.25%, Kuaishou rises 5.48%

The three major indices of the Hong Kong stock market rose collectively at noon, with the Hang Seng Index up 0.91% and the Hang Seng TECH Index up 1.54%. The internet content and information sector led the gains, while the retail and catering sectors showed divergence. Leading stocks like Alibaba and Kuaishou surged, Haidilao performed strongly, while Meituan showed weaker performance. Capital focus is centered around technology, healthcare, and semiconductors, with macro-level capital flows and data changes affecting market sentiment. Trading volume is concentrated at high levels in leading internet stocks and the healthcare sector, highlighting the active short-term trading in the market

Market Heartbeat·
Market Heartbeat·

Akeso Reports Cadonilimab Outperforms PD-1 Inhibitors in First-Line PD-L1-Low Gastric Cancer Study

Akeso Inc. reported that cadonilimab plus chemotherapy outperformed PD-1 inhibitors in a study for first-line treatment of advanced gastric cancer with PD-L1 CPS

Reuters·
HK
09926
-0.74%
Reuters·
HK
09926
-0.74%

The Hang Seng Index rose 268 points in half a day, with the 27,000 mark "gained and lost," as innovative drug stocks collectively surged. Three new stocks had a weak finish｜Hong Kong Stock Market Afternoon Session

The Hang Seng Index opened 350 points higher this morning, reaching a maximum of 27,143 points during the day, and closed at 26,877 points, up 268 points or 1.01%. Alibaba rose 3.5%, JD.com rose 1.11%, and Tencent rose 0.48%; Xiaomi, Meituan, and Baidu, on the other hand, declined. Innovative drug stocks collectively rose, with WuXi AppTec up 7.67% and CSPC PHARMA up 5.5%. Automotive stocks generally rose due to the consensus reached on electric vehicles between China and Europe, with BYD up 3.19%. The newly listed stocks today showed volatility, with Zhaoyi Innovation once rising over 53.5%

Stheadline·
Stheadline·

Innovent Biologics Reports Positive Phase 1b Results for IBI324 in Eye Disease Trial

Innovent Biologics Inc. and Ollin Biosciences reported positive Phase 1b results for IBI324 in a clinical trial for diabetic macular edema and wet age-related macular degeneration. The study showed IBI324's superior outcomes compared to faricimab, with plans to advance to global Phase 3 studies. Full results will be presented at a symposium in February 2026.

Reuters·
HK
01801
+0.56%
Reuters·
HK
01801
+0.56%
© 2026 Longbridge｜Disclaimer